139 related articles for article (PubMed ID: 16250644)
21. Synthesis and biological affinity of new imidazo- and indol-arylpiperazine derivatives: further validation of a pharmacophore model for alpha(1)-adrenoceptor antagonists.
Strappaghetti G; Mastrini L; Lucacchini A; Giannaccini G; Betti L; Fabbrini L
Bioorg Med Chem Lett; 2008 Sep; 18(18):5140-5. PubMed ID: 18760923
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and structure-affinity relationship investigations of 5-aminomethyl and 5-carbamoyl analogues of the antipsychotic sertindole. A new class of selective alpha1 adrenoceptor antagonists.
Balle T; Perregaard J; Larsen AK; Ramirez MT; Krøjer Søby K; Liljefors T; Andersen K
Bioorg Med Chem; 2003 Mar; 11(6):1065-78. PubMed ID: 12614894
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of new multi-target 3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with potential antidepressant effect.
Wróbel MZ; Chodkowski A; Herold F; Marciniak M; Dawidowski M; Siwek A; Starowicz G; Stachowicz K; Szewczyk B; Nowak G; Belka M; Bączek T; Satała G; Bojarski AJ; Turło J
Eur J Med Chem; 2019 Dec; 183():111736. PubMed ID: 31586817
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of new 4-butyl-arylpiperazine-3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives and evaluation for their 5-HT
Wróbel MZ; Chodkowski A; Marciniak M; Dawidowski M; Maksymiuk A; Siwek A; Nowak G; Turło J
Bioorg Chem; 2020 Apr; 97():103662. PubMed ID: 32086055
[TBL] [Abstract][Full Text] [Related]
25. Discovery of the first potent, selective 5-hydroxytryptamine1D receptor antagonist.
Ward SE; Harrington FP; Gordon LJ; Hopley SC; Scott CM; Watson JM
J Med Chem; 2005 May; 48(10):3478-80. PubMed ID: 15887956
[TBL] [Abstract][Full Text] [Related]
26. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
Martínez-Esparza J; Oficialdegui AM; Pérez-Silanes S; Heras B; Orús L; Palop JA; Lasheras B; Roca J; Mourelle M; Bosch A; Del Castillo JC; Tordera R; Del Río J; Monge A
J Med Chem; 2001 Feb; 44(3):418-28. PubMed ID: 11462981
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological screening of novel indolalkyl arenes targeting the serotonine transporter.
Ojeda-Gómez C; Pessoa-Mahana H; Iturriaga-Vásquez P; Pessoa-Mahana CD; Recabarren-Gajardo G; Méndez-Rojas C
Arch Pharm (Weinheim); 2014 Mar; 347(3):174-84. PubMed ID: 24339227
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
Hatzenbuhler NT; Evrard DA; Harrison BL; Huryn D; Inghrim J; Kraml C; Mattes JF; Mewshaw RE; Zhou D; Hornby G; Lin Q; Smith DL; Sullivan KM; Schechter LE; Beyer CE; Andree TH
J Med Chem; 2006 Jul; 49(15):4785-9. PubMed ID: 16854086
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of novel N
Nirogi RV; Bandyala TR; Gangadasari PR; Khagga M
J Enzyme Inhib Med Chem; 2016; 31(sup1):1-15. PubMed ID: 27806648
[TBL] [Abstract][Full Text] [Related]
30. 8-[2-(4-Aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors--part II.
Bromidge SM; Bertani B; Borriello M; Bozzoli A; Faedo S; Gianotti M; Gordon LJ; Hill M; Zucchelli V; Watson JM; Zonzini L
Bioorg Med Chem Lett; 2009 Apr; 19(8):2338-42. PubMed ID: 19286377
[TBL] [Abstract][Full Text] [Related]
31. New indole derivatives as potent and selective serotonin uptake inhibitors.
Malleron JL; Guérémy C; Mignani S; Peyronel JF; Truchon A; Blanchard JC; Doble A; Laduron P; Piot O; Zundel JL
J Med Chem; 1993 Apr; 36(9):1194-202. PubMed ID: 8487257
[TBL] [Abstract][Full Text] [Related]
32. Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonist.
Macdonald GJ; Branch CL; Hadley MS; Johnson CN; Nash DJ; Smith AB; Stemp G; Thewlis KM; Vong AK; Austin NE; Jeffrey P; Winborn KY; Boyfield I; Hagan JJ; Middlemiss DN; Reavill C; Riley GJ; Watson JM; Wood M; Parker SG; Ashby CR
J Med Chem; 2003 Nov; 46(23):4952-64. PubMed ID: 14584946
[TBL] [Abstract][Full Text] [Related]
33. [Design, synthesis and bioactivity of aryl piperazine benzo[b][1,4]oxazine derivatives].
Zheng YY; Xie P; Zhang J; Li JQ; Guo L; Yu LP; Zhou B
Yao Xue Xue Bao; 2012 Jun; 47(6):755-63. PubMed ID: 22919723
[TBL] [Abstract][Full Text] [Related]
34. Interactions of N-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-2-aryl-2-yl-acetamides and 1-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-3-aryl-2-yl-ureas with dopamine D2 and 5-hydroxytryptamine 5HT(1A) receptors.
Sukalovic V; Ignjatovic D; Tovilovic G; Andric D; Shakib K; Kostic-Rajacic S; Soskic V
Bioorg Med Chem Lett; 2012 Jun; 22(12):3967-72. PubMed ID: 22607670
[TBL] [Abstract][Full Text] [Related]
35. Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 2: asymmetric synthesis and biological evaluation.
Zhao H; He X; Thurkauf A; Hoffman D; Kieltyka A; Brodbeck R; Primus R; Wasley JW
Bioorg Med Chem Lett; 2002 Nov; 12(21):3111-5. PubMed ID: 12372513
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.
Mahaney PE; Kim CY; Coghlan RD; Cohn ST; Heffernan GD; Huselton CA; Terefenko EA; Vu AT; Zhang P; Burroughs KD; Cosmi SA; Bray JA; Johnston GH; Deecher DC; Trybulski EJ
Bioorg Med Chem Lett; 2009 Oct; 19(19):5807-10. PubMed ID: 19713106
[TBL] [Abstract][Full Text] [Related]
37.
Hogendorf A; Hogendorf AS; Kurczab R; Satała G; Szewczyk B; Cieślik P; Latacz G; Handzlik J; Lenda T; Kaczorowska K; Staroń J; Bugno R; Duszyńska B; Bojarski AJ
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361754
[TBL] [Abstract][Full Text] [Related]
38. Succinimide derivatives. II. Synthesis and antipsychotic activity of N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-1,2-cis- cyclohexanedicarboximide (SM-9018) and related compounds.
Ishizumi K; Kojima A; Antoku F; Saji I; Yoshigi M
Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2139-51. PubMed ID: 8582016
[TBL] [Abstract][Full Text] [Related]
39. New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants.
Martínez J; Pérez S; Oficialdegui AM; Heras B; Orús L; Villanueva H; Palop JA; Roca J; Mourelle M; Bosch A; Del Castillo JC; Lasheras B; Tordera R; del Río J; Monge A
Eur J Med Chem; 2001 Jan; 36(1):55-61. PubMed ID: 11231049
[TBL] [Abstract][Full Text] [Related]
40. (S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.
TenBrink RE; Bergh CL; Duncan JN; Harris DW; Huff RM; Lahti RA; Lawson CF; Lutzke BS; Martin IJ; Rees SA; Schlachter SK; Sih JC; Smith MW
J Med Chem; 1996 Jun; 39(13):2435-7. PubMed ID: 8691438
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]